Ralpancizumab is a selective monoclonal antibody inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), a regulator of LDL receptor degradation. While primarily studied in cardiovascular research, Ralpancizumab is also being investigated for its potential role in hemorrhagic stroke models, offering insights into lipid metabolism and vascular injury.
Ralpancizumab is a selective monoclonal antibody inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), a regulator of LDL receptor degradation. While primarily studied in cardiovascular research, Ralpancizumab is also being investigated for its potential role in hemorrhagic stroke models, offering insights into lipid metabolism and vascular injury.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
